| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/17/1997 | EP0795011A1 Method and compositions for reducing cholesterol absorption |
| 09/17/1997 | EP0795010A2 Stabilized ribozyme analogs |
| 09/17/1997 | EP0795008A1 Chondrocyte cell-lines |
| 09/17/1997 | EP0795006A1 HUMAN MutT2 |
| 09/17/1997 | EP0795005A1 New e.coli mutant with suppressed organic acid production |
| 09/17/1997 | EP0794966A1 Humanized antibodies to cd38 |
| 09/17/1997 | EP0794965A1 Factor vii fragment 82-128 and its use in blood-clotting disorders |
| 09/17/1997 | EP0794963A2 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells |
| 09/17/1997 | EP0794958A1 Pcr amplification of rearranged genomic variable regions of immunoglobulin genes |
| 09/17/1997 | EP0794798A2 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy |
| 09/17/1997 | EP0794797A1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 09/17/1997 | EP0794792A1 Method of promoting an immune response with a bispecific antibody |
| 09/17/1997 | CN1159833A Transgenic plants producing trehalose |
| 09/17/1997 | CN1159832A Nucleic acid fragment and products derived therefrom |
| 09/17/1997 | CN1159831A Vaccines containing borrelia burgdorferi OSPG |
| 09/17/1997 | CN1159830A Immunomodulators |
| 09/17/1997 | CN1159829A 17q-linked breast and ovarian cancer susceptibility gene |
| 09/17/1997 | CN1159828A Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 09/17/1997 | CN1159827A FLT-4 (fms-like tyrosine-kinase), FLT-15, variants thereof uses as growth factor inhibitors |
| 09/17/1997 | CN1159811A Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 09/17/1997 | CN1159739A Use of saponin for pathogen control |
| 09/17/1997 | CN1159480A Monobleb viras currier capable of being used in packaging recombination of adenovirus concomitant virus and use thereof |
| 09/17/1997 | CN1035886C Dye Transfer inhibiting compositions |
| 09/16/1997 | US5668298 Selectable marker for development of vectors and transformation systems in plants |
| 09/16/1997 | US5668297 Deacetylase genes for the production of phosphinothricin or phosphinothricyl-alanyl-alanine, process for their isolation, and their use |
| 09/16/1997 | US5668295 Protein involved in nicotine synthesis, DNA encoding, and use of sense and antisense DNAs corresponding thereto to affect nicotine content in transgenic tobacco cells and plants |
| 09/16/1997 | US5668294 Metal resistance sequences and transgenic plants |
| 09/16/1997 | US5668292 Use of plant fatty acyl hydroxylases to produce hydroxylated fatty acids and derivatives in plants |
| 09/16/1997 | US5668267 Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein |
| 09/16/1997 | US5668265 Anticoagulants |
| 09/16/1997 | US5668264 High affinity PDGF nucleic acid ligands |
| 09/16/1997 | US5668263 Conserved yeast nucleic acid sequences |
| 09/16/1997 | US5668256 Chimeric interleukin 5-receptor/immunoglobulin polypeptides |
| 09/16/1997 | US5668255 Hybrid molecules having translocation region and cell-binding region |
| 09/16/1997 | US5668108 Preparation of functional human factor VIII and pharmaceutical treatment therewith |
| 09/16/1997 | US5668013 Antigen recognized by patients with antibody associated paraneoplastic cerebellar degeneration, DNA encoding same and uses thereof |
| 09/16/1997 | US5668012 Platelet endothelial cell adhesion molecule-1 promoters and uses thereof |
| 09/16/1997 | US5668009 Methods for treating cotton-containing fabrics with CBH I enriched cellulase |
| 09/16/1997 | US5668007 Recombinant 21 kD cocoa protein and precursor |
| 09/16/1997 | US5668006 Somatostatin receptors |
| 09/16/1997 | US5668005 Cloned genes encoding reverse transcriptase lacking RNASE H activity |
| 09/16/1997 | US5668002 DNA and polypeptide for tumor-associated antigen CO-029 |
| 09/16/1997 | US5668001 Drug for inhibition of cholesterol synthesis |
| 09/16/1997 | US5668000 Yeast expression plasmid |
| 09/16/1997 | US5667998 Efficient gene transfer into primary lymphocytes obviating the need for drug selection |
| 09/16/1997 | US5667997 Biosynthesis of medium chain fatty acids |
| 09/16/1997 | US5667994 Amplification and detection of mycobacterium avium complex species |
| 09/16/1997 | US5667992 Mammalian expression systems for HCV proteins |
| 09/16/1997 | US5667991 Recombinant mersacidin and a method for production |
| 09/16/1997 | US5667990 Aspergillus expression system |
| 09/16/1997 | US5667989 Fungal cell wall Protein CLY4 |
| 09/16/1997 | US5667988 Gene expression and genes with antibodies and antigens |
| 09/16/1997 | US5667986 Yeast promoter for expressing heterologous polypeptides |
| 09/16/1997 | US5667981 Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein |
| 09/16/1997 | US5667973 Chimeric genes expressing hybrid proteins |
| 09/16/1997 | US5667969 Alteration of sequence of a deleterious target molecule by ribozyme catalyzed trans-splicing |
| 09/16/1997 | US5667966 Mouse monoclonal antibodies to Hepatitis E virus and methods for using same |
| 09/16/1997 | US5667965 Papillomavirus E2 trans-activation repressors |
| 09/16/1997 | US5667839 Human recombinant collagen in the milk of transgenic animals |
| 09/16/1997 | US5667780 Sensory and motor neuron derived factor and binding |
| 09/16/1997 | US5667777 Gene therapy for treatment of glomerular kidney disease, expression of beta-galactosidase |
| 09/16/1997 | US5667491 Method for rapid temporal control of molecular transport across tissue |
| 09/16/1997 | CA1339466C Vaccine |
| 09/16/1997 | CA1339464C ¬leu13| motilin, dnas coding for same and methods for producing same |
| 09/15/1997 | CA2200012A1 Plasmid entrapping multilamellar liposomes |
| 09/13/1997 | CA2175549A1 Expression and secretion of heterologous polypeptides from caulobacter |
| 09/12/1997 | WO1997032997A2 Malignant human cell transformation detection method |
| 09/12/1997 | WO1997032996A1 Direct molecular diagnosis of friedreich ataxia |
| 09/12/1997 | WO1997032994A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 09/12/1997 | WO1997032992A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages |
| 09/12/1997 | WO1997032991A2 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 09/12/1997 | WO1997032990A1 Methods for transducing cells in blood vessels using recombinant aav vectors |
| 09/12/1997 | WO1997032989A2 Recombinant aav vector-based transduction system and use of same |
| 09/12/1997 | WO1997032988A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 09/12/1997 | WO1997032987A1 Methods and nucleic immunogenic compositions encoding antigens and co-stimulatory molecules for immunization |
| 09/12/1997 | WO1997032986A2 Process for the production of degradation and/or conversion products of storage substances present in transgenic plant material with the help of a malting process |
| 09/12/1997 | WO1997032985A1 Nucleic acid molecules coding for debranching enzymes from maize |
| 09/12/1997 | WO1997032984A1 DIABETES MELLITUS 37 kD AUTOANTIGEN PROTEIN-TYROSINE PHOSPHATASE |
| 09/12/1997 | WO1997032983A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| 09/12/1997 | WO1997032982A1 Human adhesion molecule occludin |
| 09/12/1997 | WO1997032981A1 Down-regulation resistant c3 convertase |
| 09/12/1997 | WO1997032980A1 Transferrin receptor genes of moraxella |
| 09/12/1997 | WO1997032979A1 Inhibition of proliferation of cells |
| 09/12/1997 | WO1997032978A1 Production of human hemoglobin in transgenic animals |
| 09/12/1997 | WO1997032977A1 Plastid transformation in arabidopsis thaliana |
| 09/12/1997 | WO1997032974A1 Alpha-galactosidase |
| 09/12/1997 | WO1997032973A1 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound |
| 09/12/1997 | WO1997032900A1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 09/12/1997 | WO1997032895A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/12/1997 | WO1997032891A2 Conjugate for modifying interactions between proteins |
| 09/12/1997 | WO1997032889A1 MURINE α(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 09/12/1997 | WO1997032888A1 Substituted nucleic acid mimics |
| 09/12/1997 | WO1997032887A1 Oligonucleotide analogues |
| 09/12/1997 | WO1997032645A1 Automated nucleic acid extraction from samples |
| 09/12/1997 | WO1997032608A1 Genetically engineered primary oligodendrocytes for transplantation-mediated gene delivery in the central nervous system |
| 09/12/1997 | WO1997032603A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 09/12/1997 | WO1997032601A1 Method of screening apoptosis inducing substances |
| 09/12/1997 | WO1997032481A1 Helper-free, totally defective adenovirus for gene therapy |
| 09/12/1997 | WO1997032473A1 DNA SEQUENCES ENCODING HUMAN Myt1 KINASE |
| 09/12/1997 | WO1997026365A3 Transgenic maize with increased mannitol content |